Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. 

CEO
Christophe Weber
CEOChristophe Weber
Employees
47,455
Employees47,455
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,455
Employees47,455

TAK Key Statistics

Market cap
56.54B
Market cap56.54B
Price-Earnings ratio
73.12
Price-Earnings ratio73.12
Dividend yield
3.30%
Dividend yield3.30%
Average volume
2.53M
Average volume2.53M
High today
$17.90
High today$17.90
Low today
$17.75
Low today$17.75
Open price
$17.85
Open price$17.85
Volume
2.23M
Volume2.23M
52 Week high
$18.82
52 Week high$18.82
52 Week low
$12.99
52 Week low$12.99

TAK News

TipRanks 4d
Takeda-Backed Phase 3 Lung Cancer Trial Pits Novel IBI363 Against Docetaxel

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. The phase 3 study “A Randomized, Open-Label, Multicenter, Phase 3 Stud...

Analyst ratings

53%

of 15 ratings
Buy
53.3%
Hold
40%
Sell
6.7%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.